• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Hormonal Crosstalk Between Thyroid and Breast Cancer.甲状腺与乳腺癌的激素串扰
Endocrinology. 2022 Jul 1;163(7). doi: 10.1210/endocr/bqac075.
2
[Hormonal therapy in oncologic treatment: pathogenic hypotheses and interactions between thyroid and breast pathologies].[肿瘤治疗中的激素疗法:甲状腺与乳腺疾病之间的发病机制假说及相互作用]
Tumori. 2003 Jul-Aug;89(4 Suppl):215-9.
3
Sex hormones and breast cancer risk and prognosis.性激素与乳腺癌风险和预后
Breast. 2013 Aug;22 Suppl 2:S38-43. doi: 10.1016/j.breast.2013.07.007.
4
Regulation of cell growth by estrogen signaling and potential targets in thyroid cancer.雌激素信号传导对细胞生长的调节及甲状腺癌中的潜在靶点。
Curr Cancer Drug Targets. 2008 Aug;8(5):367-77. doi: 10.2174/156800908785133150.
5
Mechanisms of crosstalk between endocrine systems: regulation of sex steroid hormone synthesis and action by thyroid hormones.内分泌系统间的相互作用机制:甲状腺激素对性激素合成及作用的调节
Gen Comp Endocrinol. 2014 Jul 1;203:69-85. doi: 10.1016/j.ygcen.2014.03.015. Epub 2014 Mar 29.
6
The prediction of hormonal dependency of mammary cancer.乳腺癌激素依赖性的预测。
Ann Surg. 1975 Sep;182(3):342-52. doi: 10.1097/00000658-197509000-00017.
7
Sex steroid induced apoptosis as a rational strategy to treat anti-hormone resistant breast and prostate cancer.性类固醇诱导的细胞凋亡作为治疗抗激素耐药性乳腺癌和前列腺癌的合理策略。
Discov Med. 2016 May;21(117):411-27.
8
Mechanisms of endocrine resistance and novel therapeutic strategies in breast cancer.乳腺癌内分泌耐药机制及新型治疗策略
Endocr Relat Cancer. 2005 Dec;12(4):721-47. doi: 10.1677/erc.1.00857.
9
Cancer of the breast. Endocrine and hormonal therapy.乳腺癌。内分泌及激素治疗。
Major Probl Clin Surg. 1979;5:361-404.
10
Endocrine therapy in cancer.癌症的内分泌治疗
Practitioner. 1979 Feb;222(1328):211-7.

引用本文的文献

1
Global, regional, and national burden of Pediatric and adolescent thyroid cancer from 1990 to 2021: a statistical analysis of prevalence, incidence, and DALYs.1990年至2021年全球、区域和国家儿童及青少年甲状腺癌负担:患病率、发病率和伤残调整生命年的统计分析
Front Oncol. 2025 Jul 29;15:1630648. doi: 10.3389/fonc.2025.1630648. eCollection 2025.
2
Exploring the molecular mechanisms of comorbidity between thyroid cancer and breast cancer through multi-omics data.通过多组学数据探索甲状腺癌和乳腺癌共病的分子机制。
Sci Rep. 2025 Jul 2;15(1):23309. doi: 10.1038/s41598-025-06566-w.
3
TP53 gene mutation in lymphoepithelioma‑like carcinoma of the breast with thyroid cancer: A case report.乳腺伴甲状腺癌的淋巴上皮瘤样癌中的TP53基因突变:一例报告
Oncol Lett. 2025 Mar 26;29(5):247. doi: 10.3892/ol.2025.14993. eCollection 2025 May.
4
Dermatomyositis following resection of thyroid and breast cancer: a case report and literature review.甲状腺癌和乳腺癌切除术后发生皮肌炎:一例报告及文献综述
Front Oncol. 2025 Jan 21;15:1474481. doi: 10.3389/fonc.2025.1474481. eCollection 2025.
5
Breast cancer and neoplasms of the thyroid gland: a bidirectional two-sample Mendelian randomization study.乳腺癌与甲状腺肿瘤:一项双向双样本孟德尔随机化研究。
Front Oncol. 2024 Oct 14;14:1422009. doi: 10.3389/fonc.2024.1422009. eCollection 2024.
6
A review of complex hormone regulation in thyroid cancer: novel insights beyond the hypothalamus-pituitary-thyroid axis.甲状腺癌中复杂激素调节的综述:下丘脑-垂体-甲状腺轴之外的新见解。
Front Endocrinol (Lausanne). 2024 Jul 22;15:1419913. doi: 10.3389/fendo.2024.1419913. eCollection 2024.
7
Secular Increasing Trends in Female Thyroid Cancer Incidence in Taiwan.台湾女性甲状腺癌发病率的长期上升趋势。
Life (Basel). 2024 Jun 26;14(7):809. doi: 10.3390/life14070809.
8
The Role of Lipid Metabolism Disorders in the Development of Thyroid Cancer.脂代谢紊乱在甲状腺癌发展中的作用。
Int J Mol Sci. 2024 Jun 28;25(13):7129. doi: 10.3390/ijms25137129.
9
Development of a prediction model for the association between thyroid dysfunction and breast cancer.甲状腺功能障碍与乳腺癌关联预测模型的开发
Transl Cancer Res. 2024 Jun 30;13(6):2790-2798. doi: 10.21037/tcr-23-2164. Epub 2024 Jun 24.
10
Thyroid Hormone Changes Correlate to Combined Breast Cancer with Primary Thyroid Cancer.甲状腺激素变化与乳腺癌合并原发性甲状腺癌相关。
Breast Cancer (Dove Med Press). 2024 Jan 9;16:15-22. doi: 10.2147/BCTT.S442707. eCollection 2024.

本文引用的文献

1
Risk of breast cancer with HRT depends on therapy type and duration.激素替代疗法(HRT)的乳腺癌风险取决于治疗类型和持续时间。
BMJ. 2022 Mar 8;376:o485. doi: 10.1136/bmj.o485.
2
Association Between Radioactive Iodine Treatment for Pediatric and Young Adulthood Differentiated Thyroid Cancer and Risk of Second Primary Malignancies.放射性碘治疗儿童和青年分化型甲状腺癌与第二原发恶性肿瘤风险的关系。
J Clin Oncol. 2022 May 1;40(13):1439-1449. doi: 10.1200/JCO.21.01841. Epub 2022 Jan 19.
3
Low thyroid hormone receptor alpha-2 (THRα-2) tumor expression is associated with unfavorable tumor characteristics and high breast cancer mortality.甲状腺激素受体α-2(THRα-2)肿瘤表达水平低与肿瘤不良特征和高乳腺癌死亡率相关。
Breast Cancer Res. 2021 Dec 20;23(1):117. doi: 10.1186/s13058-021-01496-7.
4
Risk of primary breast cancer in patients with differentiated thyroid cancer undergoing radioactive iodine therapy: a systematic review and meta-analysis.放射性碘治疗分化型甲状腺癌患者原发性乳腺癌风险的系统评价和荟萃分析。
Eur J Nucl Med Mol Imaging. 2022 Apr;49(5):1630-1639. doi: 10.1007/s00259-021-05625-4. Epub 2021 Nov 25.
5
Change in Thyroid Hormone Metabolite Concentrations Across Different Thyroid States.甲状腺激素代谢产物浓度在不同甲状腺状态下的变化。
Thyroid. 2022 Feb;32(2):119-127. doi: 10.1089/thy.2021.0453. Epub 2022 Jan 20.
6
Differential Effects of Estrogen Receptor Alpha and Beta on Endogenous Ligands of Peroxisome Proliferator-Activated Receptor Gamma in Papillary Thyroid Cancer.雌激素受体α和β对甲状腺乳头状癌细胞过氧化物酶体增殖物激活受体γ内源性配体的差异影响。
Front Endocrinol (Lausanne). 2021 Sep 7;12:708248. doi: 10.3389/fendo.2021.708248. eCollection 2021.
7
Does Radioactive Iodine Therapy for Hyperthyroidism Cause Cancer?放射性碘治疗甲状腺功能亢进会致癌吗?
J Clin Endocrinol Metab. 2022 Jan 18;107(2):e448-e457. doi: 10.1210/clinem/dgab700.
8
Thyroid Hormone Receptor Beta as Tumor Suppressor: Untapped Potential in Treatment and Diagnostics in Solid Tumors.甲状腺激素受体β作为肿瘤抑制因子:实体瘤治疗与诊断中的未开发潜力
Cancers (Basel). 2021 Aug 24;13(17):4254. doi: 10.3390/cancers13174254.
9
Papillary Thyroid Cancer-Promoting Activities of Combined Oral Contraceptive Components.复方口服避孕药成分促进甲状腺乳头状癌的作用
Galen Med J. 2020 May 21;9:e1648. doi: 10.31661/gmj.v9i0.1648. eCollection 2020.
10
Androgen Activity Is Associated With PD-L1 Downregulation in Thyroid Cancer.雄激素活性与甲状腺癌中PD-L1下调相关。
Front Cell Dev Biol. 2021 Aug 6;9:663130. doi: 10.3389/fcell.2021.663130. eCollection 2021.

甲状腺与乳腺癌的激素串扰

Hormonal Crosstalk Between Thyroid and Breast Cancer.

机构信息

Division of Endocrinology and Diabetes, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.

Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.

出版信息

Endocrinology. 2022 Jul 1;163(7). doi: 10.1210/endocr/bqac075.

DOI:10.1210/endocr/bqac075
PMID:35587175
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9653009/
Abstract

Differentiated thyroid cancer and breast cancer account for a significant portion of endocrine-related malignancies and predominately affect women. As hormonally responsive tissues, the breast and thyroid share endocrine signaling. Breast cells are responsive to thyroid hormone signaling and are affected by altered thyroid hormone levels. Thyroid cells are responsive to sex hormones, particularly estrogen, and undergo protumorigenic processes upon estrogen stimulation. Thyroid and sex hormones also display significant transcriptional crosstalk that influences oncogenesis and treatment sensitivity. Obesity-related adipocyte alterations-adipocyte estrogen production, inflammation, feeding hormone dysregulation, and metabolic syndromes-promote hormonal alterations in breast and thyroid tissues. Environmental toxicants disrupt endocrine systems, including breast and thyroid homeostasis, and influence pathologic processes in both organs through hormone mimetic action. In this brief review, we discuss the hormonal connections between the breast and thyroid and perspectives on hormonal therapies for breast and thyroid cancer. Future research efforts should acknowledge and further explore the hormonal crosstalk of these tissues in an effort to further understand the prevalence of thyroid and breast cancer in women and to identify potential therapeutic options.

摘要

分化型甲状腺癌和乳腺癌在与内分泌相关的恶性肿瘤中占很大比例,主要影响女性。作为激素反应性组织,乳房和甲状腺具有共同的内分泌信号。乳腺细胞对甲状腺激素信号有反应,并受甲状腺激素水平改变的影响。甲状腺细胞对性激素,特别是雌激素有反应,在雌激素刺激下发生促肿瘤发生过程。甲状腺和性激素之间也存在显著的转录交叉对话,影响着肿瘤发生和治疗敏感性。肥胖相关的脂肪细胞改变——脂肪细胞产生雌激素、炎症、摄食激素失调和代谢综合征——促进乳腺和甲状腺组织的激素改变。环境毒物会破坏包括乳腺和甲状腺在内的内分泌系统的平衡,并通过激素模拟作用影响这两个器官的病理过程。在这篇简短的综述中,我们讨论了乳腺和甲状腺之间的激素联系,以及对乳腺和甲状腺癌激素治疗的看法。未来的研究工作应该认识到并进一步探索这些组织之间的激素相互作用,以进一步了解女性中甲状腺和乳腺癌的普遍存在,并确定潜在的治疗选择。